Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc. (HRTX)

$3.2

Heron Therapeutics, Inc. (HRTX) Share Price Forecast
Currently 11 wall-street analysts regularly analyze the financials of Heron Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 11 analysts offering 12-month price forecasts for Heron Therapeutics, Inc. (HRTX) have a share price target of $6.75. This median of share price forecast represents a 110.94% upside from the latest price of $3.2 as on 21.05.24.

Heron Therapeutics, Inc. (HRTX) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Heron Therapeutics, Inc. (HRTX) share price will touch around $6.75 in next 12-months.
Heron Therapeutics, Inc. (HRTX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Heron Therapeutics, Inc.'s share price and its median forecast price. As on 21.05.24, the difference is -65.33%

Heron Therapeutics, Inc. (HRTX): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Heron Therapeutics, Inc. (HRTX) Share Price : Analyst Recommendation
Based on 11 analysts tracking and researching Heron Therapeutics, Inc. (HRTX) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
7
7
7
Outperform
3
3
3
Hold
1
1
1
Underperform
0
0
0
Sell
0
0
0
Heron Therapeutics, Inc. (HRTX) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Heron Therapeutics, Inc. (HRTX) is $6.75, offered by 11 analysts offering 12-month price forecasts.

Heron Therapeutics, Inc. (HRTX) has a maximum of 1.11 upside potential, based on 11 analysts offering 12-month price forecasts.

Based on 11 analysts tracking and researching Heron Therapeutics, Inc. (HRTX), 90.91% have a buy recommendation. Remaining 9.09% have either sell or hold recommendations.

The latest share price of Heron Therapeutics, Inc. (HRTX) is $3.2 as of 21/05/2024.

10 of total 11 analysts offering stock ratings for Heron Therapeutics, Inc. HRTX have recommended buy rating.